Ossianix
Steve has spent the last 20 years in Pharma and Biotech both managing research organizations and research projects. Prior to joining Ossianix in 2012, he was site head at the Translational Medicine Research Collaboration laboratory in Dundee, Scotland. Prior to that, he managed GI biology research at Glaxo Smith Kline UK in the Neurology/GI CEDD and at Smith Kline Beecham Neuroscience he was a team leader in Neurodegeneration. Steve received his Ph.D. in Biochemistry from the Institute of Neurology, University of London and worked at Guys & St Thomas’s Medical School, as Principal Medical Laboratory Scientist in Experimental Pathology before joining industry.
This person is not in any offices
Ossianix
OSSIANIX, INC is a privately held pre-clinical company that develops Biotherapeutic products using the highly versatile single domain VNAR antibody from the shark.